HIGHLAND CAPITAL MANAGEMENT LP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 59 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$315,000
-45.8%
15,0000.0%0.02%
-25.0%
Q3 2018$581,000
+47.5%
15,000
+50.0%
0.03%
+45.5%
Q2 2018$394,000
-60.5%
10,000
-81.0%
0.02%
-50.0%
Q3 2017$997,00052,5000.04%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders